Cargando…

Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study

It has been reported that 5.1–7.0% of acute pericarditis are carcinomatous pericarditis. Malignant pericardial effusion (MPE) can progress to cardiac tamponade, which is a life-threatening condition. The effectiveness and feasibility of intrapericardial instillation of carboplatin (CBDCA; 150 mg/bod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imai, Hisao, Kaira, Kyoichi, Masubuchi, Ken, Minato, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774651/ https://www.ncbi.nlm.nih.gov/pubmed/35049689 http://dx.doi.org/10.3390/curroncol29010015

Ejemplares similares

Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study
por: Kotake, Mie, et al.
Publicado: (2019)

Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primaryon-small-cell lung cancer
por: Moriya, T, et al.
Publicado: (2000)

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)
por: Kunitoh, H, et al.
Publicado: (2009)

Voluminous Intrapericardial Lipoma Mimicking Pericardial Effusion
por: Prado de Morais, Fabíola, et al.
Publicado: (2020)

Clinical significance of post‐progression survival in lung cancer
por: Imai, Hisao, et al.
Publicado: (2017)

Unusual intrapericardial pressure pattern in localized pericardial effusion
por: Yalonetsky, Sergey, et al.
Publicado: (2020)

Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide
por: Imai, Hisao, et al.
Publicado: (2016)

Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients
por: Chen, Dawei, et al.
Publicado: (2016)

Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion
por: Numico, Gianmauro, et al.
Publicado: (2016)

Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival
por: Imai, Hisao, et al.
Publicado: (2021)

Effects of intrapericardial administration after catheter drainage on malignant pericardial effusion in non‐small cell lung cancer: A real‐world study
por: Wei, Jingwen, et al.
Publicado: (2023)

Intrapericardial Doppler Flow Signals in a Patient with Postsurgical Pericardial Effusion
por: Mancuso, Luigi, et al.
Publicado: (2017)

Clinical Impact of Post-progression Survival in Patients with Locally Advanced Non-small Cell Lung Cancer After Chemoradiotherapy
por: Imai, Hisao, et al.
Publicado: (2022)

Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review
por: Chen, Dawei, et al.
Publicado: (2015)

Intermittent administration of atezolizumab with combined carboplatin and etoposide therapy for patients with extensive‑disease small cell lung cancer
por: Tsuda, Takeshi, et al.
Publicado: (2023)

Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations
por: Imai, Hisao, et al.
Publicado: (2021)

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival
por: Masubuchi, Ken, et al.
Publicado: (2022)

The efficacy and safety of complete pericardial drainage by means of intrapericardial fibrinolysis for the prevention of complications of pericardial effusion: a systematic review protocol
por: Kakia, Aloysious, et al.
Publicado: (2016)

Management of Malignant Pericardial Effusion
por: Petrofsky, Mary
Publicado: (2014)

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2022)

Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer
por: Shiono, Ayako, et al.
Publicado: (2022)

A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients
por: Imai, Hisao, et al.
Publicado: (2017)

Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion
por: He, Dongyun, et al.
Publicado: (2022)

Clinical impact of post‐progression survival on overall survival in elderly patients with extensive disease small‐cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2016)

Pericardial Window Formation Complicated by Intrapericardial Diaphragmatic Hernia
por: Docekal, Jeremy, et al.
Publicado: (2014)

Post‐progression survival is highly linked to overall survival in patients with non‐small‐cell lung cancer harboring sensitive EGFR mutations treated with first‐line epidermal growth factor receptor‐tyrosine kinase inhibitors
por: Imai, Hisao, et al.
Publicado: (2019)

The Efficacy, Safety, and Side Effects of Intrapericardial Triamcinolone Treatment in Children with Post-surgical Pericardial Effusion: A Case Series
por: van der Werff, Manon H., et al.
Publicado: (2021)

Lung Adenocarcinoma Presenting as Malignant Pericardial Effusion/Tamponade
por: Vemireddy, Lalitha Padmanabha, et al.
Publicado: (2021)

Advanced lung cancer presenting with malignant pericardial effusion
por: Sadiq, Abid M., et al.
Publicado: (2021)

Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis
por: Imai, Hisao, et al.
Publicado: (2018)

Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations
por: Yamada, Yutaka, et al.
Publicado: (2021)

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer
por: Wasamoto, Satoshi, et al.
Publicado: (2023)

The Prognostic Impact of Pericardial Fluid Cytology in Malignant Pericardial Effusion
por: Sezenöz, Burak, et al.
Publicado: (2023)

Intrapericardial Thymoma Presented as Pericardial Tamponade with Post-Operative Myasthenia Gravis
por: Tsai, Yueh-Hsun, et al.
Publicado: (2022)

Malignant pericardial effusion: sclerotherapy or local chemotherapy?
por: Lestuzzi, C, et al.
Publicado: (2009)

Survival post surgery for malignant pericardial effusion
por: Nguyen, Olivier, et al.
Publicado: (2011)

A case series of malignant pericardial effusion
por: Babu, Reshma S., et al.
Publicado: (2022)

Permanent indwelling catheter for the management of refractory malignant pericardial effusion
por: Pustelnik, Frederik Schultz, et al.
Publicado: (2022)

Pericardial effusion
por: Marchiori, Edson, et al.
Publicado: (2021)

Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g5k2c3a446p6nc401rp5u4r7jt